A carregar...
Sodium-Glucose Cotransporter 2 Inhibitors: Possible Anti-Atherosclerotic Effects Beyond Glucose Lowering
The new drug for type 2 diabetes, the sodium-glucose cotransporter 2 (SGLT-2) inhibitor, is reversible inhibitor of SGLT-2, leading to reduction of renal glucose reabsorption and decrease of plasma glucose, in an insulin-independent manner. In addition to glucose control, the management of coronary...
Na minha lista:
| Publicado no: | J Clin Med Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elmer Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4676340/ https://ncbi.nlm.nih.gov/pubmed/26668677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2385w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|